LOUIS J PAGLIA
CIK 1199584 · last filed 2023-05-08
LOUIS J PAGLIA is a corporate insider who has filed 34 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ACGLO, was dated May 8, 2023. Across all open-market trades the lifetime net is +$316.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.15M
6
34
$316.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACGLO | Director | 54,056 | $18.90 | $1.02M | $0 | 6 | 2023-05-08 |
| Sarissa Capital Acquisition Corp. (SRSAU) Delisted | Director | 6,000 | $10.04 | $60.2K | $61.5K | 1 | 2020-10-27 |
| Bioverativ Inc. (BIVV) Delisted | Director | 0 | — | — | $234.9K | 7 | 2018-03-08 |
| ACGL | Director | 21,573 | $98.61 | $2.13M | $0 | 4 | 2017-05-08 |
| NorthStar Asset Management Group Inc. (NSAM) Delisted | Director | 104,811 | — | — | $0 | 3 | 2017-01-04 |
| NORTHSTAR REALTY FINANCE CORP. (NRF) Delisted | Director | 63,121 | — | — | $20.4K | 12 | 2016-06-22 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-08 | ACGLO | Grant (A) | +1,714 | $0 | EDGAR |
| 2022-05-06 | ACGLO | Grant (A) | +2,642 | $0 | EDGAR |
| 2021-05-10 | ACGLO | Grant (A) | +3,143 | $0 | EDGAR |
| 2020-10-27 | Sarissa Capital Acquisition Corp. (SRSAU) Delisted | Buy (P) | +6,000 | $61.5K | EDGAR |
| 2020-05-11 | ACGLO | Grant (A) | +10,116 | $0 | EDGAR |
| 2019-05-09 | ACGLO | Grant (A) | +6,558 | $0 | EDGAR |
| 2018-05-11 | ACGLO | Grant (A) | +2,770 | $0 | EDGAR |
| 2018-03-08 | Bioverativ Inc. (BIVV) Delisted | Mixed | −5,056 | $0 | EDGAR |
| 2018-02-02 | Bioverativ Inc. (BIVV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-08-08 | Bioverativ Inc. (BIVV) Delisted | Buy (P) | +2,000 | $119.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.